(Q46647666)

23 December 2017

title

Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma (English)

1 reference

23 December 2017

main subject

Merkel cell carcinoma

1 reference

7

1 reference

23 December 2017

Markus Brunner

object named as

Markus Brunner

1

0 references

Gregor Heiduschka

object named as

Gregor Heiduschka

5

0 references

Boban M Erovic

object named as

Boban M Erovic

8

0 references

author name string

Dietmar Thurnher

2

1 reference

23 December 2017

Johannes Pammer

3

1 reference

23 December 2017

Silvana Geleff

4

1 reference

23 December 2017

Christina M Reinisch

6

1 reference

23 December 2017

publication date

11 April 2008

1 reference

23 December 2017

published in

Modern Pathology

1 reference

23 December 2017

volume

21

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

876-884

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/modpathol.2008.63

exact match

0 references

cites work

Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

Merkel cell carcinoma. Prognosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

Mcl-1 is a relevant molecular target for antisense oligonucleotide strategies in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

Hematopoietic stem cell senescence and long-term bone marrow injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

Epidemiology of primary Merkel cell carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma): an overview on management

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Merkel cell carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Sunitinib in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

c-kit expression in primary and metastatic merkel cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

KIT receptor (CD117) expression in Merkel cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

CD117 (KIT receptor) expression in Merkel cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

TdT expression in Merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

[Immunohistochemical analysis of EGFR and HER-2 in patients with metastasizing melanoma, Merkel carcinoma and squamous cell carcinoma of the skin]

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Oncogenic kinase signalling

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

RTK mutations and human syndromeswhen good receptors turn bad.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Cell signaling by receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Aberrant Tyrosine Phosphorylation in Head and Neck Tumours and Potentially Premalignant Tissues

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Receptor tyrosine kinases as targets for anticancer drugs

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Biology of platelet-derived growth factor and its involvement in disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenib

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

An update on molecular genetics of gastrointestinal stromal tumours.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Antisense oligonucleotide-based therapeutics for cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

MCL-1 expression in B-cell non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Antisense therapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Functional analysis of the human MCL-1 gene

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Expression of apoptotic regulators and their significance in cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

mir-29 regulates Mcl-1 protein expression and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Polycombing the genome: PcG, trxG, and chromatin silencing

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Mammary stem cells, self-renewal pathways, and carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

When does the presence of the target predict response to the targeted agent?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.63

7 January 2021

10.1038/MODPATHOL.2008.63

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017